Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma

L Wood; M Palmer; J Hewitt; R Urtasun; E Bruera; E Rapp; JF Thaell

doi:10.1038/bjc.1998.100

Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma

British Journal of Cancer ◽

10.1038/bjc.1998.100 ◽

1998 ◽

Vol 77 (4) ◽

pp. 627-631 ◽

Cited By ~ 25

Author(s):

L Wood ◽

M Palmer ◽

J Hewitt ◽

R Urtasun ◽

E Bruera ◽

...

Keyword(s):

Small Cell Lung Carcinoma ◽

Controlled Trial ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

First Line ◽

Double Blind ◽

Cell Lung Carcinoma ◽

Double Blind Placebo ◽

P Glycoprotein

Download Full-text

A multicentre phase III randomised double-blind placebo controlled trial of pravastatin added to first-line chemotherapy in patients with non-small cell lung cancer (LungStar 2 trial)

http://isrctn.org/> ◽

10.1186/isrctn45605573 ◽

2013 ◽

Author(s):

Michael Seckl

Keyword(s):

Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Line Chemotherapy

Download Full-text

A multicentre, phase III, randomised, double-blind, placebo-controlled trial of pravastatin added to first-line chemotherapy in patients with small cell lung cancer

http://isrctn.org/> ◽

10.1186/isrctn56306957 ◽

2012 ◽

Author(s):

Michael Seckl

Keyword(s):

Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Line Chemotherapy

Download Full-text

P193b A DOUBLE BLIND RANDOMIZED CONTROLLED TRIAL ON ORAL NUTRITIONAL SUPPLEMENTATION OF OMEGA-3 FATTY ACIDS IN NON-SMALL CELL LUNG CARCINOMA

Clinical Nutrition Supplements ◽

10.1016/s1744-1161(08)70256-4 ◽

2008 ◽

Vol 3 ◽

pp. 111

Author(s):

B.S. van der Meij ◽

J.A. Languis ◽

V. van Adrichem ◽

M.D. Spreeuwenberg ◽

E.F. Smit ◽

...

Keyword(s):

Fatty Acids ◽

Small Cell Lung Carcinoma ◽

Controlled Trial ◽

Small Cell ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Small Cell Lung ◽

Double Blind ◽

Cell Lung Carcinoma ◽

Randomized Controlled

Download Full-text

NCIC CTG BR.26: A phase III randomized, double blind, placebo controlled trial of dacomitinib versus placebo in patients with advanced/metastatic non-small cell lung cancer (NSCLC) who received prior chemotherapy and an EGFR TKI.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8036 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8036-8036 ◽

Cited By ~ 6

Author(s):

Peter Michael Ellis ◽

Geoffrey Liu ◽

Michael Millward ◽

Francesco Perrone ◽

Frances A. Shepherd ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Prior Chemotherapy ◽

Egfr Tki

Download Full-text

C1-03: A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283190.70038.e9 ◽

2007 ◽

Vol 2 (8) ◽

pp. S359 ◽

Cited By ~ 3

Author(s):

Siow-Ming Lee ◽

Penella J. Woll ◽

Robin M. Rudd ◽

Nicole H. Gower ◽

Christian H. Ottensmeier ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

118TiP A multicenter, randomized, double-blind, placebo-controlled phase III trial of camrelizumab plus chemotherapy with or without radiation therapy (RT) as first-line treatment for patients with brain metastatic non-small cell lung cancer (BM-NSCLC; CTONG2003): Trial in progress

Annals of Oncology ◽

10.1016/j.annonc.2021.10.136 ◽

2021 ◽

Vol 32 ◽

pp. S1426-S1427

Author(s):

J. Yang ◽

Y. Pan ◽

F. Ning ◽

L. Lin ◽

X. Hu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

First Line Treatment

Download Full-text

Double blind, placebo controlled trial of oral lactoferrin in combination therapy for first line non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7141 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7141-7141

Author(s):

Y. Wang ◽

E. Yankee ◽

A. Varadhachary

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A multicenter, randomized, double-blind, placebo-controlled phase III study of apatinib or placebo plus gefitinib as first-line treatment in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps9116 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS9116-TPS9116

Author(s):

Hongyun Zhao ◽

Zhonghan Zhang ◽

Fan Luo ◽

Yuxiang Ma ◽

Wenfeng Fang ◽

...

Keyword(s):

Small Cell ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

A phase III randomised, double blind, placebo controlled trial of carboplatin/etoposide with or without thalidomide in small cell lung cancer

http://isrctn.org/> ◽

10.1186/isrctn16174527 ◽

2013 ◽

Author(s):

Siow Ming Lee

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Phase III randomized double blind placebo controlled trial of cisplatin(P) and etoposide (E) plus megestrol acetate (M)/placebo in extensive stage small cell lung cancer (SCLC)

Lung Cancer ◽

10.1016/0169-5002(94)94116-5 ◽

1994 ◽

Vol 11 ◽

pp. 90 ◽

Cited By ~ 1

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Extensive Stage

Download Full-text